July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Margherita Ambrosini Highlights ARMANI Trial Findings in HER2-Negative Gastric Cancer at ASCO 2025
Jun 1, 2025, 06:00

Margherita Ambrosini Highlights ARMANI Trial Findings in HER2-Negative Gastric Cancer at ASCO 2025

Margherita Ambrosini, Medical Doctor, Oncology Clinical and Research Fellow at the Fondazione IRCCS National Cancer Institute in Milan, posted on LinkedIn:

“Switch maintenance with paclitaxel plus ramucirumab significantly improved key disease related symptoms and delayed clinical deterioration compared to continuation of oxaliplatin and fluoropyrimidine first line chemotherapy in patients with advanced HER2- gastric/gej cancer enrolled in the phase 3 ARMANI trial.
Pass by poster board 350 to discuss about it!”
Margherita Ambrosini Highlights ARMANI Trial Findings in HER2-Negative Gastric Cancer at ASCO 2025

More posts featuring ASCO25.